The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.39
1 yrs 0 m
1%
285.76 Crs
1% on or before 1M, Nil after 1M
Large Growth
7.61
SIP 100 & Lumpsum 500
BSE HEALTH CARE - TRI
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk